share_log

Comstock (NYSE:LODE) and Cyclo Therapeutics (NASDAQ:CYTH) Head to Head Review

Comstock (NYSE:LODE) and Cyclo Therapeutics (NASDAQ:CYTH) Head to Head Review

康斯托克(纽约证券交易所代码:LODE)和Cyclo Therapeutics(纳斯达克股票代码:CYTH)头对头审查
Defense World ·  2022/11/21 14:41

Comstock (NYSE:LODE – Get Rating) and Cyclo Therapeutics (NASDAQ:CYTH – Get Rating) are both small-cap basic materials companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, institutional ownership, profitability, analyst recommendations, valuation and dividends.

康斯托克(纽约证券交易所代码:LODE-GET)和循环治疗公司(纳斯达克:CYTH-GET评级)都是小盘股基础材料公司,但哪一项投资更具优势?我们将根据这两家公司的收益、风险、机构所有权、盈利能力、分析师建议、估值和股息等方面的实力进行比较。

Volatility & Risk

波动性与风险

Comstock has a beta of 1.68, suggesting that its share price is 68% more volatile than the S&P 500. Comparatively, Cyclo Therapeutics has a beta of -0.5, suggesting that its share price is 150% less volatile than the S&P 500.

Comstock的贝塔系数为1.68,这表明其股价的波动性比标准普尔500指数高68%。相比之下,Cyclo Treateutics的贝塔系数为-0.5,这表明其股价的波动性比标准普尔500指数低150%。

Get
到达
Comstock
康斯托克
alerts:
警报:

Profitability

盈利能力

This table compares Comstock and Cyclo Therapeutics' net margins, return on equity and return on assets.

此表比较了Comstock和Cyclo治疗公司的净利润率、股本回报率和资产回报率。

Net Margins Return on Equity Return on Assets
Comstock -7,762.50% -25.38% -17.24%
Cyclo Therapeutics -747.63% -120.38% -95.12%
净利润率 股本回报率 资产回报率
康斯托克 -7,762.50% -25.38% -17.24%
Cycle治疗公司 -747.63% -120.38% -95.12%

Valuation & Earnings

估值与收益

This table compares Comstock and Cyclo Therapeutics' top-line revenue, earnings per share (EPS) and valuation.
此表比较了Comstock和Cyclo治疗公司的营收、每股收益(EPS)和估值。
Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Comstock $860,000.00 36.72 -$24.58 million ($0.68) -0.54
Cyclo Therapeutics $1.59 million 5.97 -$14.29 million ($1.58) -0.71
总收入 价格/销售额比 净收入 每股收益 市盈率
康斯托克 $860,000.00 36.72 -2,458万元 ($0.68) -0.54
Cycle治疗公司 159万美元 5.97 -1,429万元 ($1.58) -0.71

Cyclo Therapeutics has higher revenue and earnings than Comstock. Cyclo Therapeutics is trading at a lower price-to-earnings ratio than Comstock, indicating that it is currently the more affordable of the two stocks.

Cycle治疗公司的收入和收益比康斯托克公司高。Cycle治疗公司的市盈率低于Comstock,这表明它目前是两只股票中更负担得起的一只。

Institutional and Insider Ownership

机构和内部人持股

6.0% of Comstock shares are owned by institutional investors. Comparatively, 4.8% of Cyclo Therapeutics shares are owned by institutional investors. 16.4% of Comstock shares are owned by insiders. Comparatively, 12.0% of Cyclo Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

康斯托克6.0%的股份由机构投资者持有。相比之下,机构投资者持有Cyclo Treateutics 4.8%的股份。康斯托克16.4%的股份由内部人士持有。相比之下,Cyclo治疗公司12.0%的股份由内部人士持有。强大的机构持股表明,捐赠基金、大型基金管理公司和对冲基金相信,一家公司的长期表现将好于大盘。

Analyst Ratings

分析师评级

This is a summary of current ratings and recommmendations for Comstock and Cyclo Therapeutics, as reported by MarketBeat.

这是MarketBeat报道的Comstock和Cyclo治疗公司目前的评级和推荐摘要。

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Comstock 0 0 0 0 N/A
Cyclo Therapeutics 0 0 0 0 N/A
销售评级 保持评级 购买评级 强劲的买入评级 评级分数
康斯托克 0 0 0 0 不适用
Cycle治疗公司 0 0 0 0 不适用

Summary

摘要

Comstock beats Cyclo Therapeutics on 8 of the 11 factors compared between the two stocks.

Comstock在两只股票之间比较的11个因素中有8个击败了Cyclo Treeutics。

About Comstock

康斯托克公司简介

(Get Rating)

(获取评级)

Comstock Inc. engages in the exploration, development, and production of mineral properties in Nevada. The company explores for gold, silver, lithium, nickel, cobalt, and mercury ores. It operates in two segments, Mining and Real Estate. The Mining segment owns and controls approximately 9,358 acres of mining claims and parcels, including approximately 2,396 acres of patented claims and surface parcels; and approximately 6,962 acres of unpatented mining claims in the Comstock and Silver City districts, as well as focuses on exploring and developing properties in the Lucerne and Dayton resource areas; and Occidental and Gold Hill mineral properties. The Real Estate segment comprises land and real estate rental properties, as well as the Gold Hill Hotel and Daney Ranch properties. It has collaboration agreements with Oro Industries Inc. and Mercury Clean Up, LLC for the manufacture and deployment of mercury remediation systems with proprietary mechanical, hydro, electro-chemical, and oxidation processes to reclaim and remediate mercury from soils, waste, and tailings. The company was formerly known as Comstock Mining Inc. and changed its name to Comstock Inc. in May 2022. Comstock Inc. was incorporated in 2008 and is based in Virginia City, Nevada.

康斯托克公司在内华达州从事矿产资源的勘探、开发和生产。该公司勘探金、银、锂、镍、钴和汞矿石。它分为两个部门,矿业和房地产。矿业部门拥有及控制约9,358英亩采矿权及地块,包括约2,396英亩有专利权的矿权及地表地块;以及康斯托克及银城地区约6,962英亩的非专利矿业权,并专注于勘探及开发卢塞恩及代顿资源区的矿产;以及西方及Gold Hill矿产。房地产部门包括土地和房地产租赁物业,以及金山酒店和丹尼牧场物业。该公司与Oro Industries Inc.和Merht Clean Up,LLC签署了合作协议,制造和部署汞修复系统,该系统采用专有的机械、水力、电化学和氧化工艺,以回收和修复土壤、废物和尾矿中的汞。该公司前身为Comstock Mining Inc.,并于2022年5月更名为Comstock Inc.。康斯托克公司成立于2008年,总部设在内华达州弗吉尼亚州。

About Cyclo Therapeutics

关于Cyclo治疗

(Get Rating)

(获取评级)

Cyclo Therapeutics, Inc., a clinical stage biotechnology company, develops cyclodextrin-based products for the treatment of various diseases. Its lead drug candidate is Trappsol Cyclo, an orphan drug, which is Phase III clinical trials for the treatment of Niemann-Pick Type C disease. The company also develops Trappsol Cyclo for the treatment of Alzheimer's disease. In addition, it sells cyclodextrins and related products to the pharmaceutical, nutritional, and other industries, primarily for use in diagnostics and specialty drugs. The company was formerly known as CTD Holdings, Inc. and changed its name to Cyclo Therapeutics, Inc. in September 2019. Cyclo Therapeutics, Inc. was incorporated in 1990 and is based in Gainesville, Florida.

Cyclo治疗公司是一家临床阶段生物技术公司,开发以环糊精为基础的产品,用于治疗各种疾病。它的主要候选药物是Trappsol Cyclo,这是一种孤儿药物,是治疗Niemann-Pick C型疾病的第三阶段临床试验。该公司还开发了用于治疗阿尔茨海默病的Trappsol Cyclo。此外,它还向制药、营养和其他行业销售环糊精和相关产品,主要用于诊断和特殊药物。该公司前身为CTD控股公司,并于2019年9月更名为Cyclo治疗公司。Cyclo治疗公司成立于1990年,总部设在佛罗里达州盖恩斯维尔。

Receive News & Ratings for Comstock Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Comstock and related companies with MarketBeat.com's FREE daily email newsletter.

接受Comstock Daily的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对Comstock和相关公司的最新新闻和分析师评级的每日简要摘要。

译文内容由第三方软件翻译。


以上内容仅用作资讯或教育之目的,不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
    抢沙发